Luciferase SGC7901 Gastric Cancer Cells (SGC7901-Luc)

The SGC7901-Luc cell line is another example of a genetically modified cancer cell line that expresses luciferase, similar to the HepG2-Luc cell line. SGCThe SGC7901-Luc cell line is another cell line that has been genetically modified to express luciferase, a bioluminescent reporter enzyme. The SGC7901 cell line itself is derived from human gastric carcinoma (stomach cancer) and has been widely used in cancer research to study gastric cancer biology, tumor progression, and response to treatments.

SGC7901-Luc cell line can be used in preclinical research to monitor tumor growth, metastasis, and response to therapy using bioluminescence imaging techniques. By introducing the luciferase reporter gene into SGC7901 cells, researchers can track tumor growth in real-time and assess the effects of different therapeutic agents on tumor progression.

The SGC7901-Luc cell line has been utilized in various studies investigating the molecular mechanisms involved in gastric cancer development, metastasis, and drug resistance. Researchers have used this cell line to evaluate novel treatment strategies, including chemotherapy, targeted therapies, and immunotherapies, in preclinical models of gastric carcinoma.